Home LiteratureArticle Details
PMID: 12769641 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis.

Current drug targets. Cardiovascular & haematological disorders ·Vol. 3 ·No. 2 ·2003-06-00 ·Pages 155-85

Richardson M, Singh G

Abstract

The chorioallantoic membrane (CAM) is widely used as a model to examine angiogenesis, and anti-angiogenesis. Its advantages over mammalian systems include low cost, and ease of preparation, as well as the absence of a mature immune system. Although the use of this model presents a major opportunity to compare data generated in different laboratories, thereby expediting the evaluation of new drugs, angiogenic potential of cells and tissues, and body fluids, as well as to provide meaningful information concerning the molecular mechanisms involved, the wide range of methodologies used, especially in the quantification of the response, make any comparison essentially invalid. In this review, the major methodologies for all aspects of the use of the CAM in angiogenesis-related studies have been described. These include the source of the CAM, the methods for culture, and methods for evaluation of normal growth and of the response to an intervention. Methods for applying an intervention, the age for intervention and the duration of an intervention are documented. The structure and growth characteristics, the nature of possible responses to stimulation and inhibition of angiogenesis, and the complications of non-specific reactions have been examined. The need for a standardized approach to the use of the CAM model is obvious. One set of possible parameters is suggested.

MeSH Terms
Angiogenesis Inhibitors/pharmacology Animals Birds/physiology Capillaries/drug effects,physiology Cells, Cultured Chick Embryo Chorion/blood supply,growth & development,physiology Drug Evaluation, Preclinical Models, Biological Neovascularization, Physiologic/drug effects,physiology
Chemicals
Angiogenesis Inhibitors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Richardson Mary
Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada. mrichard@mcmaster.ca
Singh Gurmit
Article Info
Journal
Current drug targets. Cardiovascular & haematological disorders
Abbr.
Curr Drug Targets Cardiovasc Haematol Disord
ISSN
1568-0061
Published
2003-06-00
Pages
155-85
Language
English
Region
Netherlands
NLM ID
101123341
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com